Richards Pharma Solutions

Nous étions ravis de participer à Pharmacy U Montréal vendredi dernier !

Merci à toutes les personnes qui sont venues nous rencontrer à notre kiosque. Un merci tout spécial à Maude Laforest de Chronomed Inc. , notre partenaire pour la solution Chronopac, d'avoir été présente avec nous tout au long de l'événement.

-

We were delighted to attend Pharmacy U Montréal last Friday!

Thank you to everyone who stopped by our booth. A special thank you to Maude Laforest from Chronomed Inc. , our partner for the Chronopac solution, for joining us throughout the event.

We had a great weekend at the annual Canadian Association of Pharmacy Technicians - CAPT Conference!

Thank you to everyone who stopped by the Healthmark Services Ltd. booth to learn more about our workflow solutions. It was a pleasure connecting with delegates from across the industry, including Karen and Lori, to discuss how we can support their workflows.

🎉🎉 We're also honored to have been voted Most Engaging Booth in the Exhibitor Choice Awards by conference delegates. Thank you for your support and for making this event such a success!

🎙️ Le premier épisode du Richards Management Review Podcast est maintenant disponible.

Dans cet épisode inaugural, John Glynn (CEO) et Enzio DiGennaro (CFO) présentent la performance financière de l’année fiscale 2025 ainsi que l’orientation stratégique du Richards Group, dont Richards Pharma fait fièrement partie.

🎧 Écoutez le premier épisode dès aujourd’hui ! https://na3.hubs.ly/y0m-hR0

-

🎙️ The first episode of the Richards Management Review Podcast is now available.

In this inaugural episode, John Glynn (CEO) and Enzio DiGennaro (CFO) review the company’s fiscal 2025 performance and discuss the strategic direction of the Richards Group, of which Richards Pharma is proud to be a part.

🎧 Listen to the first episode today! https://na3.hubs.ly/y0m-hR0

2025 Richards Group Management Review In the first episode of the Richards Management Review podcast, CEO John Glynn and CFO Enzio DiGennaro review the company’s fiscal 2025 performance and strat...